BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21712551)

  • 21. [Heavy chain diseases].
    Nouv Presse Med; 1979 Nov; 8(44):3609-10. PubMed ID: 118431
    [No Abstract]   [Full Text] [Related]  

  • 22. Rheumatoid arthritis associated with transient gamma 2-heavy chain disease.
    Ockhuizen T; Smit JW; van Leeuwen M
    Rheumatol Int; 1983; 3(4):167-72. PubMed ID: 6422533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Case of gamma heavy chain disease].
    Iavorkovskiĭ LI; Pushkarev IA; Guseva LN; Magalif NI; Apine RIa
    Probl Gematol Pereliv Krovi; 1978 Dec; (12):33-9. PubMed ID: 106378
    [No Abstract]   [Full Text] [Related]  

  • 24. Heavy chain disease, rheumatoid arthritis and cryoglobulinemia.
    Kretschmer RR; Pizzuto J; González J; López M
    Clin Immunol Immunopathol; 1974 Jan; 2(2):195-215. PubMed ID: 4816446
    [No Abstract]   [Full Text] [Related]  

  • 25. Gamma heavy chain disease DUB: clinical, immunochemical and pathological studies.
    Roda L; David MJ; Biron P; Souche S; Creyssel R
    Haematologica; 1985; 70(3):232-5. PubMed ID: 3932151
    [No Abstract]   [Full Text] [Related]  

  • 26. Heavy chain disease: our experience.
    Gulli F; Napodano C; Pocino K; Cuccaro A; Hohaus S; Basile U
    Clin Chem Lab Med; 2017 Nov; 56(1):e10-e12. PubMed ID: 28665788
    [No Abstract]   [Full Text] [Related]  

  • 27. Gamma heavy chain disease and giant lymph node hyperplasia in a patient with impaired T cell function.
    Okuda K; Himeno Y; Toyama T; Ohta M; Kitagawa M; Sugai S
    Jpn J Med; 1982 Apr; 21(2):109-14. PubMed ID: 6811785
    [No Abstract]   [Full Text] [Related]  

  • 28. Gamma heavy chain disease studied by two-dimensional electrophoresis and immuno-blotting techniques.
    Blangarin P; Deviller P; Kindbeiter K; Madjar JJ
    Clin Chem; 1984 Dec; 30(12 Pt 1):2021-5. PubMed ID: 6437695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An unrecognized immunoglobinopathy: heavy chain disease].
    Lebreton JP; Rivat C; Rivat L; Guillemot L; Ropartz C
    Presse Med (1893); 1967 Oct; 75(45):2251-4. PubMed ID: 4167867
    [No Abstract]   [Full Text] [Related]  

  • 30. Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.
    Bieliauskas S; Tubbs RR; Bacon CM; Eshoa C; Foucar K; Gibson SE; Kroft SH; Sohani AR; Swerdlow SH; Cook JR
    Am J Surg Pathol; 2012 Apr; 36(4):534-43. PubMed ID: 22301495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and biological study of heavy gamma chain disease. Apropos of a new case].
    Delmas-Marsalet Y; Voisin D; Hennache G; Bauters F; Goudemand M
    Nouv Rev Fr Hematol; 1971; 11(5):717-34. PubMed ID: 4261188
    [No Abstract]   [Full Text] [Related]  

  • 32. An unusual case of plasma cell dyscrasia with gamma heavy chains in the serum and free kappa chains in the urine.
    Marcenò R; Majolino I; Cavallaro AM; Caronia F
    Haematologica; 1984; 69(6):715-20. PubMed ID: 6441749
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum proteins: diagnostic significance of electrophoretic patterns.
    Larson PH
    Hum Pathol; 1974 Nov; 5(6):629-40. PubMed ID: 4138596
    [No Abstract]   [Full Text] [Related]  

  • 34. HEAVY CHAIN DISEASE- A NEW DISORDER OF SERUM GAMMA-GLOBULINS : REPORT OF THE FIRST CASE.
    FRANKLIN EC; LOWENSTEIN J; BIGELOW B; MELTZER M
    Am J Med; 1964 Sep; 37():332-50. PubMed ID: 14209281
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunoselection screening methods for detection of the free heavy chains.
    Ottó S; Végh Z; Kocsis G
    Immunol Lett; 1984; 8(4):211-4. PubMed ID: 6437970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of gamma-heavy chain disease during the course of diabetic nephropathy].
    Ohtani S; Mashiko T; Kanoh Y; Shimetani N; Ohtani H
    Rinsho Ketsueki; 2000 Mar; 41(3):192-7. PubMed ID: 10774247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of alpha chain disease in an African negro (author's transl)].
    Bellaiche A; Casadevall N; Louvel A; Claret Y; Varet B
    Ann Med Interne (Paris); 1980; 131(8):525-7. PubMed ID: 6784633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Test and teach. Laboratory characterisation of paraproteins. Heavy chain disease.
    Chan MH; Cheung RC; Lam CW
    Pathology; 2001 Aug; 33(3):379-81. PubMed ID: 11523944
    [No Abstract]   [Full Text] [Related]  

  • 39. [Heavy chain disease--including alpha chain disease].
    Takatsuki K
    Nihon Rinsho; 1970 Aug; 28(8):2053-9. PubMed ID: 4918338
    [No Abstract]   [Full Text] [Related]  

  • 40. Huge discrepancy between serum immunoglobulin concentration and proteinemia due to heavy chain disease.
    Feugray G; Fontaine C; Lanic H; Guillerme J; Quillard Muraine M
    Clin Biochem; 2022 Oct; 108():10-13. PubMed ID: 35779576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.